This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
and to facilitate access to health
generic
products
in Greece
important market share and is an
established player in the Greek
Pharma Industry / is ranked
amongst the major pharma
companies in Greece.
development and manufacturing
to commercialisation, Medicair has
throughout the years created a portfolio
of off-patent blockbuster, value-added
and niche medicines, covering all major
therapeutic areas.
pharmaceutical company based in Greece.
is a never
ending
process
monitoring different
markets, we do not
cease investigating
emerging trends and are
constantly looking for
new opportunities both
in and out-bound.
of turnover
in R&D
new
developments
yearly
90
32
25
240
and success locally, following the construction
of our own manufacturing facilities in 2012,
we began focusing on the distribution of our
products globally.
We have established solid strategic
partnerships with major pharma companies
for the licensing of our developments and the
distribution of our own branded medicines.
leads to unmatched, tailormade
solutions, to cover
the particular needs of any
client. Our manufacturing
capacity can cover from small
to large-scale projects with
efficiency and consistency.
Strict measures are in place,
safeguarding that every
single product coming out
of our premises is of high
quality, while at the same
time meeting all regulations
and registration policies.
reasons for
selecting
Medicair for
Production
and
Development